{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:29:11Z","timestamp":1793503751719,"version":"4.5.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universidad Aut\u00f3noma de Madrid","id":[{"id":"https:\/\/ror.org\/01cby8j38","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The hypothalamic-pituitary region can be affected by a wide and heterogeneous group of infiltrative and inflammatory disorders, including granulomatous, histiocytic, storage, infectious, non-pituitary neoplastic, and autoimmune or inflammatory conditions collectively grouped as hypophysitis. Although individually rare, these disorders are increasingly recognized due to growing awareness, wider use of pituitary imaging, and the emergence of immune checkpoint inhibitor-induced hypophysitis. They typically present with hypopituitarism (often including arginine vasopressin deficiency, which, particularly when accompanied by pituitary stalk thickening, is highly suggestive of a non-adenomatous lesion) together with mass effect symptoms and, in many cases, systemic manifestations reflecting extrapituitary organ involvement. Neuroimaging findings, while rarely pathognomonic, can narrow the differential diagnosis, particularly when pituitary stalk involvement is present: symmetric stalk\/gland enlargement with homogeneous enhancement suggests lymphocytic, IgG4-related, or granulomatous hypophysitis, whereas rim enhancement, necrosis, or bone-destructive lesions point toward infectious or neoplastic causes. A structured diagnostic work-up, combining clinical history, hormonal evaluation, targeted laboratory testing, pituitary and systemic imaging, and, when necessary, histopathological confirmation, is essential to establish an accurate diagnosis before committing patients to long-term immunosuppression or unnecessary pituitary surgery. Management requires two parallel strategies: prompt hormone replacement therapy, with urgent attention to corticotroph deficiency, and disease-specific treatment tailored to the underlying etiology, ranging from glucocorticoids and immunosuppressants to antimicrobial therapy, targeted oncologic agents, or surgery. Because pituitary deficits are frequently irreversible and several of these disorders follow a relapsing course, long-term multidisciplinary follow-up is warranted. This review summarizes the pathophysiology, clinical presentation, diagnostic approach and neuroimaging features, for infiltrative and inflammatory hypothalamic-pituitary disorders, aiming to facilitate their timely recognition and appropriate management.<\/jats:p>","DOI":"10.1007\/s11102-026-01758-7","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:19:26Z","timestamp":1789586366000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Infiltrative and inflammatory systemic disorders involving the pituitary gland"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8837-4343","authenticated-orcid":false,"given":"Betina","family":"Biagetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Sarria-Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manel","family":"Puig-Domingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Araujo-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Marazuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"1758_CR1","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41574-025-01200-1","volume":"22","author":"L Miquel","year":"2026","unstructured":"Miquel L, Testud B, Albarel F et al (2026) An update on hypophysitis. Nat Rev Endocrinol 22:287\u2013301. https:\/\/doi.org\/10.1038\/s41574-025-01200-1","journal-title":"Nat Rev Endocrinol"},{"key":"1758_CR2","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1016\/S0140-6736(24)00342-8","volume":"403","author":"M Fleseriu","year":"2024","unstructured":"Fleseriu M, Christ-Crain M, Langlois F et al (2024) Hypopituitarism Lancet 403:2632\u20132648. https:\/\/doi.org\/10.1016\/S0140-6736(24)00342-8","journal-title":"Hypopituitarism Lancet"},{"key":"1758_CR3","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1016\/S0140-6736(16)30053-8","volume":"388","author":"CE Higham","year":"2016","unstructured":"Higham CE, Johannsson G, Shalet SM (2016) Hypopituitarism Lancet 388:2403\u20132415. https:\/\/doi.org\/10.1016\/S0140-6736(16)30053-8","journal-title":"Hypopituitarism Lancet"},{"key":"1758_CR4","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.beem.2009.05.009","volume":"23","author":"R Carpinteri","year":"2009","unstructured":"Carpinteri R, Patelli I, Casanueva FF, Giustina A (2009) Pituitary tumours: inflammatory and granulomatous expansive lesions of the pituitary. Best Pract Res Clin Endocrinol Metab 23:639\u2013650. https:\/\/doi.org\/10.1016\/j.beem.2009.05.009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"1758_CR5","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.endien.2023.01.001","volume":"70","author":"P Iglesias","year":"2023","unstructured":"Iglesias P, Biagetti B, Guerrero-P\u00e9rez F et al (2023) Executive summary of the consensus document on hypophysitis of the Neuroendocrinology Area of Knowledge of the Spanish Society of Endocrinology and Nutrition. Endocrinol Diabetes Nutr (Engl Ed) 70(Suppl 1):116\u2013125. https:\/\/doi.org\/10.1016\/j.endien.2023.01.001","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"key":"1758_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s11102-025-01626-w","volume":"29","author":"E B\u0131y\u0131kl\u0131","year":"2026","unstructured":"B\u0131y\u0131kl\u0131 E, Aybal T, Aslan B, Ekinci G (2026) Pituitary stalk thickening: can a multiparametric MRI approach improve etiologic prediction? Pituitary 29:26. https:\/\/doi.org\/10.1007\/s11102-025-01626-w","journal-title":"Pituitary"},{"key":"1758_CR7","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.tem.2019.06.004","volume":"30","author":"S Chiloiro","year":"2019","unstructured":"Chiloiro S, Capoluongo ED, Tartaglione T et al (2019) The Changing Clinical Spectrum of Hypophysitis. Trends Endocrinol Metab 30:590\u2013602. https:\/\/doi.org\/10.1016\/j.tem.2019.06.004","journal-title":"Trends Endocrinol Metab"},{"key":"1758_CR8","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1210\/clinem\/dgag113","volume":"111","author":"D Erickson","year":"2026","unstructured":"Erickson D, Donegan D, Erickson BJ, Van Gompel J (2026) Approach to Patient: Stalk Lesions of the Pituitary Gland. J Clin Endocrinol Metab 111:2089\u20132100. https:\/\/doi.org\/10.1210\/clinem\/dgag113","journal-title":"J Clin Endocrinol Metab"},{"key":"1758_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11102-025-01617-x","volume":"29","author":"AO \u0130\u015fler","year":"2025","unstructured":"\u0130\u015fler AO, Sendur SN, Gocmen R et al (2025) An endocrinological point of view on a large series of pituitary stalk lesions. Pituitary 29:11. https:\/\/doi.org\/10.1007\/s11102-025-01617-x","journal-title":"Pituitary"},{"key":"1758_CR10","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1210\/jc.2018-02297","volume":"104","author":"X Zhou","year":"2019","unstructured":"Zhou X, Zhu H, Yao Y et al (2019) Etiological Spectrum and Pattern of Change in Pituitary Stalk Thickening: Experience in 321 Patients. J Clin Endocrinol Metab 104:3419\u20133427. https:\/\/doi.org\/10.1210\/jc.2018-02297","journal-title":"J Clin Endocrinol Metab"},{"key":"1758_CR11","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1210\/er.2004-0011","volume":"26","author":"P Caturegli","year":"2005","unstructured":"Caturegli P, Newschaffer C, Olivi A et al (2005) Autoimmune Hypophysitis. Endocr Rev 26:599\u2013614. https:\/\/doi.org\/10.1210\/er.2004-0011","journal-title":"Endocr Rev"},{"key":"1758_CR12","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1093\/ejendo\/lvad003","volume":"188","author":"J Honegger","year":"2023","unstructured":"Honegger J, Giese S, Nasi-Kordhishti I, Donegan DM (2023) Pregnancy-related hypophysitis revisited. Eur J Endocrinol 188:R1\u2013R12. https:\/\/doi.org\/10.1093\/ejendo\/lvad003","journal-title":"Eur J Endocrinol"},{"key":"1758_CR13","doi-asserted-by":"publisher","first-page":"3841","DOI":"10.1210\/jc.2015-2152","volume":"100","author":"J Honegger","year":"2015","unstructured":"Honegger J, Schlaffer S, Menzel C et al (2015) Diagnosis of Primary Hypophysitis in Germany. J Clin Endocrinol Metab 100:3841\u20133849. https:\/\/doi.org\/10.1210\/jc.2015-2152","journal-title":"J Clin Endocrinol Metab"},{"key":"1758_CR14","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1210\/clinem\/dgab839","volume":"107","author":"D Donegan","year":"2022","unstructured":"Donegan D, Saeed Z, Delivanis DA et al (2022) Outcomes of Initial Management Strategies in Patients With Autoimmune Lymphocytic Hypophysitis: A Systematic Review and Meta-analysis. J Clin Endocrinol Metab 107:1170\u20131190. https:\/\/doi.org\/10.1210\/clinem\/dgab839","journal-title":"J Clin Endocrinol Metab"},{"key":"1758_CR15","doi-asserted-by":"publisher","first-page":"e1767","DOI":"10.1210\/clinem\/dgae664","volume":"110","author":"L Miquel","year":"2025","unstructured":"Miquel L, Testud B, Albarel F et al (2025) Deciphering the Presentation and Etiologies of Hypophysitis Highlights the Need for Repeated Systematical Investigation. J Clin Endocrinol Metab 110:e1767\u2013e1775. https:\/\/doi.org\/10.1210\/clinem\/dgae664","journal-title":"J Clin Endocrinol Metab"},{"key":"1758_CR16","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.eprac.2022.06.009","volume":"28","author":"D Donegan","year":"2022","unstructured":"Donegan D, Honegger J (2022) Hypophysitis. Endocr Pract 28:901\u2013910. https:\/\/doi.org\/10.1016\/j.eprac.2022.06.009","journal-title":"Endocr Pract"},{"key":"1758_CR17","doi-asserted-by":"publisher","unstructured":"Sahin S, Yildiz G, Oguz SH et al (2022) Discrimination between non-functioning pituitary adenomas and hypophysitis using machine learning methods based on magnetic resonance imaging\u2013derived texture features. Pituitary. https:\/\/doi.org\/10.1007\/s11102-022-01213-3","DOI":"10.1007\/s11102-022-01213-3"},{"key":"1758_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1055\/s-0037-1604079","volume":"79","author":"S Pekic","year":"2018","unstructured":"Pekic S, Bogosavljevic V, Peker S et al (2018) Lymphocytic Hypophysitis Successfully Treated with Stereotactic Radiosurgery: Case Report and Review of the Literature. J Neurol Surg Cent Eur Neurosurg 79:77\u201385. https:\/\/doi.org\/10.1055\/s-0037-1604079","journal-title":"J Neurol Surg Cent Eur Neurosurg"},{"key":"1758_CR19","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1186\/s13256-021-03146-0","volume":"15","author":"M Kruse","year":"2021","unstructured":"Kruse M, Olesen TB, Markovic L et al (2021) Recurrent autoimmune hypophysitis treated with rituximab: a case report. J Med Case Rep 15:591. https:\/\/doi.org\/10.1186\/s13256-021-03146-0","journal-title":"J Med Case Rep"},{"key":"1758_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1530\/eje.1.02183","volume":"155","author":"A Gutenberg","year":"2006","unstructured":"Gutenberg A, Hans V, Puchner MJA et al (2006) Primary hypophysitis: clinical-pathological correlations. Eur J Endocrinol 155:101\u2013107. https:\/\/doi.org\/10.1530\/eje.1.02183","journal-title":"Eur J Endocrinol"},{"key":"1758_CR21","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s11102-013-0510-4","volume":"17","author":"BHM Hunn","year":"2014","unstructured":"Hunn BHM, Martin WG, Simpson S, Mclean CA (2014) Idiopathic granulomatous hypophysitis: a systematic review of 82 cases in the literature. Pituitary 17:357\u2013365. https:\/\/doi.org\/10.1007\/s11102-013-0510-4","journal-title":"Pituitary"},{"key":"1758_CR22","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.3174\/ajnr.A7618","volume":"43","author":"IT Mark","year":"2022","unstructured":"Mark IT, Glastonbury CM (2022) Diffuse Basisphenoid Enhancement: Possible Differentiating Feature for Granulomatous Hypophysitis. AJNR Am J Neuroradiol 43:1341\u20131345. https:\/\/doi.org\/10.3174\/ajnr.A7618","journal-title":"AJNR Am J Neuroradiol"},{"key":"1758_CR23","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.jocn.2015.01.019","volume":"22","author":"B Hanna","year":"2015","unstructured":"Hanna B, Li YM, Beutler T et al (2015) Xanthomatous hypophysitis. J Clin Neurosci 22:1091\u20131097. https:\/\/doi.org\/10.1016\/j.jocn.2015.01.019","journal-title":"J Clin Neurosci"},{"key":"1758_CR24","doi-asserted-by":"publisher","first-page":"195323","DOI":"10.1155\/2010\/195323","volume":"2010","author":"L Aste","year":"2010","unstructured":"Aste L, Bellinzona M, Meleddu V et al (2010) Xanthomatous hypophysitis mimicking a pituitary adenoma: case report and review of the literature. J Oncol 2010:195323. https:\/\/doi.org\/10.1155\/2010\/195323","journal-title":"J Oncol"},{"key":"1758_CR25","doi-asserted-by":"publisher","first-page":"R151","DOI":"10.1530\/EJE-17-0009","volume":"179","author":"MN Joshi","year":"2018","unstructured":"Joshi MN, Whitelaw BC, Carroll PV (2018) MECHANISMS IN ENDOCRINOLOGY: Hypophysitis: diagnosis and treatment. Eur J Endocrinol 179:R151\u2013R163. https:\/\/doi.org\/10.1530\/EJE-17-0009","journal-title":"Eur J Endocrinol"},{"key":"1758_CR26","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1111\/bpa.12459","volume":"27","author":"C Bernreuther","year":"2017","unstructured":"Bernreuther C, Illies C, Flitsch J et al (2017) IgG4-related hypophysitis is highly prevalent among cases of histologically confirmed hypophysitis. Brain Pathol 27:839\u2013845. https:\/\/doi.org\/10.1111\/bpa.12459","journal-title":"Brain Pathol"},{"key":"1758_CR27","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s12020-021-02714-0","volume":"73","author":"A Amirbaigloo","year":"2021","unstructured":"Amirbaigloo A, Esfahanian F, Mouodi M et al (2021) IgG4-related hypophysitis. Endocrine 73:270\u2013291. https:\/\/doi.org\/10.1007\/s12020-021-02714-0","journal-title":"Endocrine"},{"key":"1758_CR28","doi-asserted-by":"publisher","first-page":"104016","DOI":"10.1016\/j.lpm.2020.104016","volume":"49","author":"M Lojou","year":"2020","unstructured":"Lojou M, Bonneville JF, Ebbo M et al (2020) IgG4 hypophysitis: Diagnosis and management. La Presse M\u00e9dicale 49:104016. https:\/\/doi.org\/10.1016\/j.lpm.2020.104016","journal-title":"La Presse M\u00e9dicale"},{"key":"1758_CR29","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1210\/jc.2010-2970","volume":"96","author":"P Leporati","year":"2011","unstructured":"Leporati P, Landek-Salgado MA, Lupi I et al (2011) IgG4-related hypophysitis: a new addition to the hypophysitis spectrum. J Clin Endocrinol Metab 96:1971\u20131980. https:\/\/doi.org\/10.1210\/jc.2010-2970","journal-title":"J Clin Endocrinol Metab"},{"key":"1758_CR30","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1002\/art.39686","volume":"68","author":"H Sekiguchi","year":"2016","unstructured":"Sekiguchi H, Horie R, Kanai M et al (2016) IgG4-Related Disease: Retrospective Analysis of One Hundred Sixty-Six Patients. Arthritis Rheumatol 68:2290\u20132299. https:\/\/doi.org\/10.1002\/art.39686","journal-title":"Arthritis Rheumatol"},{"key":"1758_CR31","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1530\/EJE-13-0642","volume":"170","author":"H Bando","year":"2014","unstructured":"Bando H, Iguchi G, Fukuoka H et al (2014) The prevalence of IgG4-related hypophysitis in 170 consecutive patients with hypopituitarism and\/or central diabetes insipidus and review of the literature. Eur J Endocrinol 170:161\u2013172. https:\/\/doi.org\/10.1530\/EJE-13-0642","journal-title":"Eur J Endocrinol"},{"key":"1758_CR32","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/cei.12805","volume":"186","author":"W Egner","year":"2016","unstructured":"Egner W, Swallow K, Lock RJ, Patel D (2016) Falsely low immunoglobulin (Ig)G4 in routine analysis: how not to miss IgG4 disease. Clin Exp Immunol 186:57\u201363. https:\/\/doi.org\/10.1111\/cei.12805","journal-title":"Clin Exp Immunol"},{"key":"1758_CR33","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1136\/annrheumdis-2014-206605","volume":"74","author":"MN Carruthers","year":"2015","unstructured":"Carruthers MN, Topazian MD, Khosroshahi A et al (2015) Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis 74:1171\u20131177. https:\/\/doi.org\/10.1136\/annrheumdis-2014-206605","journal-title":"Ann Rheum Dis"},{"key":"1758_CR34","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1093\/rheumatology\/kev438","volume":"55","author":"ZS Wallace","year":"2016","unstructured":"Wallace ZS, Mattoo H, Mahajan VS et al (2016) Predictors of disease relapse in IgG4-related disease following rituximab. Rheumatology (Oxford) 55:1000\u20131008. https:\/\/doi.org\/10.1093\/rheumatology\/kev438","journal-title":"Rheumatology (Oxford)"},{"key":"1758_CR35","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s11102-011-0307-2","volume":"15","author":"A Gutenberg","year":"2012","unstructured":"Gutenberg A, Caturegli P, Metz I et al (2012) Necrotizing infundibulo-hypophysitis: an entity too rare to be true? Pituitary 15:202\u2013208. https:\/\/doi.org\/10.1007\/s11102-011-0307-2","journal-title":"Pituitary"},{"key":"1758_CR36","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1080\/02688697.2021.1940857","volume":"38","author":"C Magalh\u00e3es-Ribeiro","year":"2024","unstructured":"Magalh\u00e3es-Ribeiro C, Furtado A, Baggen Santos R et al (2024) Necrotizing infundibulo-hypophysitis: case-report and literature review. Br J Neurosurg 38:613\u2013616. https:\/\/doi.org\/10.1080\/02688697.2021.1940857","journal-title":"Br J Neurosurg"},{"key":"1758_CR37","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s11604-023-01417-y","volume":"41","author":"R Kurokawa","year":"2023","unstructured":"Kurokawa R, Kurokawa M, Baba A et al (2023) Neuroimaging of hypophysitis: etiologies and imaging mimics. Jpn J Radiol 41:911\u2013927. https:\/\/doi.org\/10.1007\/s11604-023-01417-y","journal-title":"Jpn J Radiol"},{"key":"1758_CR38","doi-asserted-by":"publisher","first-page":"e002493","DOI":"10.1136\/jitc-2021-002493","volume":"9","author":"T Kobayashi","year":"2021","unstructured":"Kobayashi T, Iwama S, Sugiyama D et al (2021) Anti-pituitary antibodies and susceptible human leukocyte antigen alleles as predictive biomarkers for pituitary dysfunction induced by immune checkpoint inhibitors. J Immunother Cancer 9:e002493. https:\/\/doi.org\/10.1136\/jitc-2021-002493","journal-title":"J Immunother Cancer"},{"key":"1758_CR39","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41574-024-01077-6","volume":"21","author":"S Iwama","year":"2025","unstructured":"Iwama S, Kobayashi T, Arima H (2025) Management, biomarkers and prognosis in people developing endocrinopathies associated with immune checkpoint inhibitors. Nat Rev Endocrinol 21:289\u2013300. https:\/\/doi.org\/10.1038\/s41574-024-01077-6","journal-title":"Nat Rev Endocrinol"},{"key":"1758_CR40","doi-asserted-by":"publisher","first-page":"R107","DOI":"10.1530\/EJE-19-0169","volume":"181","author":"F Albarel","year":"2019","unstructured":"Albarel F, Castinetti F, Brue T (2019) MANAGEMENT OF ENDOCRINE DISEASE: Immune check point inhibitors-induced hypophysitis. Eur J Endocrinol 181:R107\u2013R118. https:\/\/doi.org\/10.1530\/EJE-19-0169","journal-title":"Eur J Endocrinol"},{"key":"1758_CR41","doi-asserted-by":"publisher","first-page":"bqae084","DOI":"10.1210\/endocr\/bqae084","volume":"165","author":"N Chamorro-Pareja","year":"2024","unstructured":"Chamorro-Pareja N, Faje AT, Miller KK (2024) Pituitary Complications of Checkpoint Inhibitor Use. Endocrinology 165:bqae084. https:\/\/doi.org\/10.1210\/endocr\/bqae084","journal-title":"Endocrinology"},{"key":"1758_CR42","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1530\/EJE-19-0238","volume":"181","author":"A Faje","year":"2019","unstructured":"Faje A, Reynolds K, Zubiri L et al (2019) Hypophysitis secondary to nivolumab and pembrolizumab is a clinical entity distinct from ipilimumab-associated hypophysitis. Eur J Endocrinol 181:211\u2013219. https:\/\/doi.org\/10.1530\/EJE-19-0238","journal-title":"Eur J Endocrinol"},{"key":"1758_CR43","doi-asserted-by":"publisher","first-page":"230ra45","DOI":"10.1126\/scitranslmed.3008002","volume":"6","author":"S Iwama","year":"2014","unstructured":"Iwama S, De Remigis A, Callahan MK et al (2014) Pituitary expression of CTLA-4 mediates hypophysitis secondary to administration of CTLA-4 blocking antibody. Sci Transl Med 6:230ra45. https:\/\/doi.org\/10.1126\/scitranslmed.3008002","journal-title":"Sci Transl Med"},{"key":"1758_CR44","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1002\/cncr.31629","volume":"124","author":"AT Faje","year":"2018","unstructured":"Faje AT, Lawrence D, Flaherty K et al (2018) High-dose glucocorticoids for the treatment of ipilimumab-induced hypophysitis is associated with reduced survival in patients with melanoma. Cancer 124:3706\u20133714. https:\/\/doi.org\/10.1002\/cncr.31629","journal-title":"Cancer"},{"key":"1758_CR45","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.3390\/jcm9103280","volume":"9","author":"M Levy","year":"2020","unstructured":"Levy M, Abeillon J, Dalle S et al (2020) Anti-PD1 and Anti-PDL1-Induced Hypophysitis: A Cohort Study of 17 Patients with Longitudinal Follow-Up. J Clin Med 9:3280. https:\/\/doi.org\/10.3390\/jcm9103280","journal-title":"J Clin Med"},{"key":"1758_CR46","doi-asserted-by":"publisher","first-page":"101371","DOI":"10.1016\/j.beem.2019.101371","volume":"33","author":"S Gubbi","year":"2019","unstructured":"Gubbi S, Hannah-Shmouni F, Verbalis JG, Koch CA (2019) Hypophysitis: An update on the novel forms, diagnosis and management of disorders of pituitary inflammation. Best Pract Res Clin Endocrinol Metab 33:101371. https:\/\/doi.org\/10.1016\/j.beem.2019.101371","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1758_CR47","doi-asserted-by":"publisher","first-page":"7900","DOI":"10.1038\/s41467-025-63183-x","volume":"16","author":"K Kanie","year":"2025","unstructured":"Kanie K, Ito T, Iguchi G et al (2025) Modeling of T cell-mediated autoimmune pituitary disease using human induced pluripotent stem cell-originated organoid. Nat Commun 16:7900. https:\/\/doi.org\/10.1038\/s41467-025-63183-x","journal-title":"Nat Commun"},{"key":"1758_CR48","doi-asserted-by":"publisher","first-page":"K1","DOI":"10.1093\/ejendo\/lvad179","volume":"190","author":"S Urai","year":"2024","unstructured":"Urai S, Iguchi G, Kanie K et al (2024) Clinical features of anti-pituitary-specific transcription factor-1 (PIT-1) hypophysitis: a new aspect of paraneoplastic autoimmune condition. Eur J Endocrinol 190:K1\u2013K7. https:\/\/doi.org\/10.1093\/ejendo\/lvad179","journal-title":"Eur J Endocrinol"},{"key":"1758_CR49","doi-asserted-by":"publisher","first-page":"125807","DOI":"10.1016\/j.jns.2026.125807","volume":"482","author":"M Herman","year":"2026","unstructured":"Herman M, Russell K, Shi H et al (2026) Neurosarcoidosis of the hypothalamus, infundibulum, and pituitary gland: A retrospective cohort study. J Neurol Sci 482:125807. https:\/\/doi.org\/10.1016\/j.jns.2026.125807","journal-title":"J Neurol Sci"},{"key":"1758_CR50","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/MD.0b013e31815585aa","volume":"86","author":"H Bihan","year":"2007","unstructured":"Bihan H, Christozova V, Dumas J-L et al (2007) Sarcoidosis: clinical, hormonal, and magnetic resonance imaging (MRI) manifestations of hypothalamic-pituitary disease in 9 patients and review of the literature. Med (Baltim) 86:259\u2013268. https:\/\/doi.org\/10.1097\/MD.0b013e31815585aa","journal-title":"Med (Baltim)"},{"key":"1758_CR51","doi-asserted-by":"publisher","first-page":"R269","DOI":"10.1530\/EJE-16-1065","volume":"176","author":"S Pekic","year":"2017","unstructured":"Pekic S, Popovic V (2017) DIAGNOSIS OF ENDOCRINE DISEASE: Expanding the cause of hypopituitarism. Eur J Endocrinol 176:R269\u2013R282. https:\/\/doi.org\/10.1530\/EJE-16-1065","journal-title":"Eur J Endocrinol"},{"key":"1758_CR52","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11102-015-0678-x","volume":"19","author":"J Anthony","year":"2016","unstructured":"Anthony J, Esper GJ, Ioachimescu A (2016) Hypothalamic-pituitary sarcoidosis with vision loss and hypopituitarism: case series and literature review. Pituitary 19:19\u201329. https:\/\/doi.org\/10.1007\/s11102-015-0678-x","journal-title":"Pituitary"},{"key":"1758_CR53","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.ro.2004.06.006","volume":"39","author":"KM Lury","year":"2004","unstructured":"Lury KM, Smith JK, Matheus MG, Castillo M (2004) Neurosarcoidosis\u2013review of imaging findings. Semin Roentgenol 39:495\u2013504. https:\/\/doi.org\/10.1016\/j.ro.2004.06.006","journal-title":"Semin Roentgenol"},{"key":"1758_CR54","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s11102-026-01753-y","volume":"29","author":"JFB Cavalcanti","year":"2026","unstructured":"Cavalcanti JFB, de Souza SC, Lucato LT et al (2026) Clinical presentation, investigation findings, and outcomes of hypophysitis in sarcoidosis: a systematic review. Pituitary 29:148. https:\/\/doi.org\/10.1007\/s11102-026-01753-y","journal-title":"Pituitary"},{"key":"1758_CR55","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.1210\/jc.2014-1962","volume":"99","author":"E Kapoor","year":"2014","unstructured":"Kapoor E, Cartin-Ceba R, Specks U et al (2014) Pituitary dysfunction in granulomatosis with polyangiitis: the Mayo Clinic experience. J Clin Endocrinol Metab 99:3988\u20133994. https:\/\/doi.org\/10.1210\/jc.2014-1962","journal-title":"J Clin Endocrinol Metab"},{"key":"1758_CR56","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s10067-019-04735-7","volume":"39","author":"A Vega-Beyhart","year":"2020","unstructured":"Vega-Beyhart A, Medina-Rangel IR, Hinojosa-Azaola A et al (2020) Pituitary dysfunction in granulomatosis with polyangiitis. Clin Rheumatol 39:595\u2013606. https:\/\/doi.org\/10.1007\/s10067-019-04735-7","journal-title":"Clin Rheumatol"},{"key":"1758_CR57","doi-asserted-by":"publisher","first-page":"e748","DOI":"10.1097\/MD.0000000000000748","volume":"94","author":"A De Parisot","year":"2015","unstructured":"De Parisot A, Pu\u00e9chal X, Langrand C et al (2015) Pituitary Involvement in Granulomatosis With Polyangiitis. Med (Baltim) 94:e748. https:\/\/doi.org\/10.1097\/MD.0000000000000748","journal-title":"Med (Baltim)"},{"key":"1758_CR58","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s11102-023-01378-5","volume":"27","author":"M Alameri","year":"2024","unstructured":"Alameri M, Alnuaimi A, Martin NM et al (2024) Pituitary hypophysitis in granulomatosis with polyangiitis (GPA): a case series. Pituitary 27:230\u2013237. https:\/\/doi.org\/10.1007\/s11102-023-01378-5","journal-title":"Pituitary"},{"key":"1758_CR59","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/rheumatology\/key117","volume":"58","author":"X Pu\u00e9chal","year":"2019","unstructured":"Pu\u00e9chal X, Iudici M, Calich AL et al (2019) Rituximab for induction and maintenance therapy of granulomatosis with polyangiitis: a single-centre cohort study on 114 patients. Rheumatology (Oxford) 58:401\u2013409. https:\/\/doi.org\/10.1093\/rheumatology\/key117","journal-title":"Rheumatology (Oxford)"},{"key":"1758_CR60","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/WNO.0000000000002249","volume":"45","author":"A-R Salman","year":"2024","unstructured":"Salman A-R, Hur M, Warrington KJ et al (2024) Etiologies and Outcomes of Granulomatosis With Polyangiitis-Associated Optic Neuropathy: A Case Series and Review of the Literature. J Neuroophthalmol 45:333\u2013337. https:\/\/doi.org\/10.1097\/WNO.0000000000002249","journal-title":"J Neuroophthalmol"},{"key":"1758_CR61","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/s0303-8467(00)00063-9","volume":"102","author":"MC Sharma","year":"2000","unstructured":"Sharma MC, Arora R, Mahapatra AK et al (2000) Intrasellar tuberculoma\u2013an enigmatic pituitary infection: a series of 18 cases. Clin Neurol Neurosurg 102:72\u201377. https:\/\/doi.org\/10.1016\/s0303-8467(00)00063-9","journal-title":"Clin Neurol Neurosurg"},{"key":"1758_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11102-025-01601-5","volume":"29","author":"A Gierlotka","year":"2025","unstructured":"Gierlotka A, Sordyl R, Bielecki I, Mandera M (2025) Pituitary tuberculosis in the pediatric population: a systematic review and case report. Pituitary 29:1. https:\/\/doi.org\/10.1007\/s11102-025-01601-5","journal-title":"Pituitary"},{"key":"1758_CR63","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s12020-025-04352-2","volume":"90","author":"A Rao","year":"2025","unstructured":"Rao A, Lila AR, Karlekar M et al (2025) Clinical and radiological insights into secondary hypophysitis: A single-center experience with a focus on tuberculosis. Endocrine 90:266\u2013275. https:\/\/doi.org\/10.1007\/s12020-025-04352-2","journal-title":"Endocrine"},{"key":"1758_CR64","doi-asserted-by":"publisher","first-page":"6568","DOI":"10.4081\/idr.2016.6568","volume":"8","author":"D Goletti","year":"2016","unstructured":"Goletti D, Petruccioli E, Joosten SA, Ottenhoff THM (2016) Tuberculosis Biomarkers: From Diagnosis to Protection. Infect Dis Rep 8:6568. https:\/\/doi.org\/10.4081\/idr.2016.6568","journal-title":"Infect Dis Rep"},{"key":"1758_CR65","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.21037\/qims.2019.05.24","volume":"9","author":"W-Y Yu","year":"2019","unstructured":"Yu W-Y, Lu P-X, Assadi M et al (2019) Updates on 18F-FDG-PET\/CT as a clinical tool for tuberculosis evaluation and therapeutic monitoring. Quant Imaging Med Surg 9:1132\u20131146. https:\/\/doi.org\/10.21037\/qims.2019.05.24","journal-title":"Quant Imaging Med Surg"},{"key":"1758_CR66","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1186\/s12889-024-19495-6","volume":"24","author":"J Yayan","year":"2024","unstructured":"Yayan J, Rasche K, Franke K-J et al (2024) FDG-PET-CT as an early detection method for tuberculosis: a systematic review and meta-analysis. BMC Public Health 24:2022. https:\/\/doi.org\/10.1186\/s12889-024-19495-6","journal-title":"BMC Public Health"},{"key":"1758_CR67","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jns.2017.06.015","volume":"379","author":"A More","year":"2017","unstructured":"More A, Verma R, Garg RK et al (2017) A study of neuroendocrine dysfunction in patients of tuberculous meningitis. J Neurol Sci 379:198\u2013206. https:\/\/doi.org\/10.1016\/j.jns.2017.06.015","journal-title":"J Neurol Sci"},{"key":"1758_CR68","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/s0899-7071(00)00181-9","volume":"24","author":"T Patankar","year":"2000","unstructured":"Patankar T, Patkar D, Bunting T et al (2000) Imaging in pituitary tuberculosis. Clin Imaging 24:89\u201392. https:\/\/doi.org\/10.1016\/s0899-7071(00)00181-9","journal-title":"Clin Imaging"},{"key":"1758_CR69","doi-asserted-by":"publisher","first-page":"e0275460","DOI":"10.1371\/journal.pone.0275460","volume":"17","author":"GSG Mannam","year":"2022","unstructured":"Mannam GSG, Kumar P V, et al (2022) Absence of posterior pituitary bright spot in adults with CNS tuberculosis: A case-control study. PLoS ONE 17:e0275460. https:\/\/doi.org\/10.1371\/journal.pone.0275460","journal-title":"PLoS ONE"},{"key":"1758_CR70","doi-asserted-by":"publisher","first-page":"110858","DOI":"10.1016\/j.jocn.2024.110858","volume":"129","author":"HS Ahmed","year":"2024","unstructured":"Ahmed HS, Shivananda DB, Pulkurthi SR et al (2024) Clinical profile and outcomes in Tolosa-Hunt Syndrome; a systematic review. J Clin Neurosci 129:110858. https:\/\/doi.org\/10.1016\/j.jocn.2024.110858","journal-title":"J Clin Neurosci"},{"key":"1758_CR71","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s11916-023-01193-4","volume":"27","author":"M Kmeid","year":"2023","unstructured":"Kmeid M, Medrea I (2023) Review of Tolosa-Hunt Syndrome, Recent Updates. Curr Pain Headache Rep 27:843\u2013849. https:\/\/doi.org\/10.1007\/s11916-023-01193-4","journal-title":"Curr Pain Headache Rep"},{"key":"1758_CR72","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1007\/s12020-017-1422-2","volume":"58","author":"R \u015awi\u0105tkowska-Stodulska","year":"2017","unstructured":"\u015awi\u0105tkowska-Stodulska R, Stodulski D, Babi\u0144ska A et al (2017) Bilateral Tolosa-Hunt syndrome mimicking pituitary adenoma. Endocrine 58:582\u2013586. https:\/\/doi.org\/10.1007\/s12020-017-1422-2","journal-title":"Endocrine"},{"key":"1758_CR73","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1182\/blood.2021014343","volume":"139","author":"G Goyal","year":"2022","unstructured":"Goyal G, Tazi A, Go RS et al (2022) International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults. Blood 139:2601\u20132621. https:\/\/doi.org\/10.1182\/blood.2021014343","journal-title":"Blood"},{"key":"1758_CR74","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1182\/blood.2019002766","volume":"135","author":"J Haroche","year":"2020","unstructured":"Haroche J, Cohen-Aubart F, Amoura Z (2020) Erdheim-Chester disease. Blood 135:1311\u20131318. https:\/\/doi.org\/10.1182\/blood.2019002766","journal-title":"Blood"},{"key":"1758_CR75","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00234-005-0011-x","volume":"48","author":"P Makras","year":"2006","unstructured":"Makras P, Samara C, Antoniou M et al (2006) Evolving radiological features of hypothalamo-pituitary lesions in adult patients with Langerhans cell histiocytosis (LCH). Neuroradiology 48:37\u201344. https:\/\/doi.org\/10.1007\/s00234-005-0011-x","journal-title":"Neuroradiology"},{"key":"1758_CR76","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1530\/EJE-19-0177","volume":"181","author":"Y Sagna","year":"2019","unstructured":"Sagna Y, Courtillot C, Drabo JY et al (2019) Endocrine manifestations in a cohort of 63 adulthood and childhood onset patients with Langerhans cell histiocytosis. Eur J Endocrinol 181:275\u2013285. https:\/\/doi.org\/10.1530\/EJE-19-0177","journal-title":"Eur J Endocrinol"},{"key":"1758_CR77","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s11102-025-01576-3","volume":"28","author":"H Masri Iraqi","year":"2025","unstructured":"Masri Iraqi H, Tsoli M, Barbot M et al (2025) Patients with langerhans cell histiocytosis and hypothalamic-pituitary involvement: insights from the HEROS study cohort. Pituitary 28:104. https:\/\/doi.org\/10.1007\/s11102-025-01576-3","journal-title":"Pituitary"},{"key":"1758_CR78","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1056\/NEJMra1607548","volume":"379","author":"CE Allen","year":"2018","unstructured":"Allen CE, Merad M, McClain KL (2018) Langerhans-Cell Histiocytosis. N Engl J Med 379:856\u2013868. https:\/\/doi.org\/10.1056\/NEJMra1607548","journal-title":"N Engl J Med"},{"key":"1758_CR79","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1182\/blood-2012-07-446286","volume":"121","author":"J Haroche","year":"2013","unstructured":"Haroche J, Cohen-Aubart F, Emile J-F et al (2013) Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation. Blood 121:1495\u20131500. https:\/\/doi.org\/10.1182\/blood-2012-07-446286","journal-title":"Blood"},{"key":"1758_CR80","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ejim.2015.03.004","volume":"26","author":"C Campochiaro","year":"2015","unstructured":"Campochiaro C, Tomelleri A, Cavalli G et al (2015) Erdheim-Chester disease. Eur J Intern Med 26:223\u2013229. https:\/\/doi.org\/10.1016\/j.ejim.2015.03.004","journal-title":"Eur J Intern Med"},{"key":"1758_CR81","doi-asserted-by":"publisher","first-page":"101845","DOI":"10.1016\/j.disamonth.2024.101845","volume":"71","author":"R Chaudhary","year":"2025","unstructured":"Chaudhary R, Kumar A, Singh A et al (2025) Erdheim-Chester disease: Comprehensive insights from genetic mutations to clinical manifestations and therapeutic advances. Dis Mon 71:101845. https:\/\/doi.org\/10.1016\/j.disamonth.2024.101845","journal-title":"Dis Mon"},{"key":"1758_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.critrevonc.2015.02.004","volume":"95","author":"M Cives","year":"2015","unstructured":"Cives M, Simone V, Rizzo FM et al (2015) Erdheim-Chester disease: a systematic review. Crit Rev Oncol Hematol 95:1\u201311. https:\/\/doi.org\/10.1016\/j.critrevonc.2015.02.004","journal-title":"Crit Rev Oncol Hematol"},{"key":"1758_CR83","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1136\/annrheumdis-2013-204924","volume":"74","author":"MG Cangi","year":"2015","unstructured":"Cangi MG, Biavasco R, Cavalli G et al (2015) BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim-Chester disease. Ann Rheum Dis 74:1596\u20131602. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204924","journal-title":"Ann Rheum Dis"},{"key":"1758_CR84","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1210\/jc.2015-3357","volume":"101","author":"C Courtillot","year":"2016","unstructured":"Courtillot C, Laugier Robiolle S, Cohen Aubart F et al (2016) Endocrine Manifestations in a Monocentric Cohort of 64 Patients With Erdheim-Chester Disease. J Clin Endocrinol Metab 101:305\u2013313. https:\/\/doi.org\/10.1210\/jc.2015-3357","journal-title":"J Clin Endocrinol Metab"},{"key":"1758_CR85","doi-asserted-by":"publisher","first-page":"122692","DOI":"10.1016\/j.lfs.2024.122692","volume":"348","author":"AM Kulkarni","year":"2024","unstructured":"Kulkarni AM, Gayam PKR, Aranjani JM (2024) Advances in Understanding and Management of Erdheim-Chester Disease. Life Sci 348:122692. https:\/\/doi.org\/10.1016\/j.lfs.2024.122692","journal-title":"Life Sci"},{"key":"1758_CR86","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s11102-010-0228-5","volume":"13","author":"F Rotondo","year":"2010","unstructured":"Rotondo F, Munoz DG, Hegele RG et al (2010) Rosai-Dorfman disease involving the neurohypophysis. Pituitary 13:256\u2013259. https:\/\/doi.org\/10.1007\/s11102-010-0228-5","journal-title":"Pituitary"},{"key":"1758_CR87","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1097\/RLU.0000000000002776","volume":"44","author":"Z Kong","year":"2019","unstructured":"Kong Z, Wang Y, Ma W, Cheng X (2019) FDG PET\/CT Image for a Rosai-Dorfman Disease With Pituitary and Bone Involvement in a Pediatric Patient. Clin Nucl Med 44:873\u2013875. https:\/\/doi.org\/10.1097\/RLU.0000000000002776","journal-title":"Clin Nucl Med"},{"key":"1758_CR88","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12883-026-04762-3","volume":"26","author":"S Huang","year":"2026","unstructured":"Huang S, Wu C, Ding J et al (2026) Isolated Intracranial Rosai-Dorfman Disease Mimicking Sellar Pituitary Adenoma: a case report and literature review. BMC Neurol 26:221. https:\/\/doi.org\/10.1186\/s12883-026-04762-3","journal-title":"BMC Neurol"},{"key":"1758_CR89","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1210\/jc.2004-0980","volume":"90","author":"JH McDermott","year":"2005","unstructured":"McDermott JH, Walsh CH (2005) Hypogonadism in hereditary hemochromatosis. J Clin Endocrinol Metab 90:2451\u20132455. https:\/\/doi.org\/10.1210\/jc.2004-0980","journal-title":"J Clin Endocrinol Metab"},{"key":"1758_CR90","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s40618-016-0451-7","volume":"39","author":"C Pelusi","year":"2016","unstructured":"Pelusi C, Gasparini DI, Bianchi N, Pasquali R (2016) Endocrine dysfunction in hereditary hemochromatosis. J Endocrinol Invest 39:837\u2013847. https:\/\/doi.org\/10.1007\/s40618-016-0451-7","journal-title":"J Endocrinol Invest"},{"key":"1758_CR91","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.4158\/EP10095.RA","volume":"16","author":"D Ozdemir","year":"2010","unstructured":"Ozdemir D, Dagdelen S, Erbas T (2010) Endocrine involvement in systemic amyloidosis. Endocr Pract 16:1056\u20131063. https:\/\/doi.org\/10.4158\/EP10095.RA","journal-title":"Endocr Pract"},{"key":"1758_CR92","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1210\/jc.2015-2049","volume":"100","author":"L Bricaire","year":"2015","unstructured":"Bricaire L, Van Haecke C, Laurent-Roussel S et al (2015) The Great Imitator in Endocrinology: A Painful Hypophysitis Mimicking a Pituitary Tumor. J Clin Endocrinol Metab 100:2837\u20132840. https:\/\/doi.org\/10.1210\/jc.2015-2049","journal-title":"J Clin Endocrinol Metab"},{"key":"1758_CR93","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11102-016-0757-7","volume":"20","author":"L Gao","year":"2017","unstructured":"Gao L, Guo X, Tian R et al (2017) Pituitary abscess: clinical manifestations, diagnosis and treatment of 66 cases from a large pituitary center over 23 years. Pituitary 20:189\u2013194. https:\/\/doi.org\/10.1007\/s11102-016-0757-7","journal-title":"Pituitary"},{"key":"1758_CR94","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jocn.2016.01.010","volume":"29","author":"LA Moore","year":"2016","unstructured":"Moore LA, Erstine EM, Prayson RA (2016) Pituitary aspergillus infection. J Clin Neurosci 29:178\u2013180. https:\/\/doi.org\/10.1016\/j.jocn.2016.01.010","journal-title":"J Clin Neurosci"},{"key":"1758_CR95","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s11154-020-09569-2","volume":"21","author":"M Marazuela","year":"2020","unstructured":"Marazuela M, Giustina A, Puig-Domingo M (2020) Endocrine and metabolic aspects of the COVID-19 pandemic. Rev Endocr Metab Disord 21:495\u2013507. https:\/\/doi.org\/10.1007\/s11154-020-09569-2","journal-title":"Rev Endocr Metab Disord"},{"key":"1758_CR96","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11154-013-9244-x","volume":"14","author":"MM George","year":"2013","unstructured":"George MM, Bhangoo A (2013) Human immune deficiency virus (HIV) infection and the hypothalamic pituitary adrenal axis. Rev Endocr Metab Disord 14:105\u2013112. https:\/\/doi.org\/10.1007\/s11154-013-9244-x","journal-title":"Rev Endocr Metab Disord"},{"key":"1758_CR97","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s11102-021-01148-1","volume":"24","author":"S Frara","year":"2021","unstructured":"Frara S, Allora A, Castellino L et al (2021) COVID-19 and the pituitary. Pituitary 24:465\u2013481. https:\/\/doi.org\/10.1007\/s11102-021-01148-1","journal-title":"Pituitary"},{"key":"1758_CR98","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/j.1365-2265.2010.03881.x","volume":"73","author":"E Valassi","year":"2010","unstructured":"Valassi E, Biller BMK, Klibanski A, Swearingen B (2010) Clinical features of nonpituitary sellar lesions in a large surgical series. Clin Endocrinol 73:798\u2013807. https:\/\/doi.org\/10.1111\/j.1365-2265.2010.03881.x","journal-title":"Clin Endocrinol"},{"key":"1758_CR99","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s11102-013-0542-9","volume":"17","author":"R Al-Aridi","year":"2014","unstructured":"Al-Aridi R, El Sibai K, Fu P et al (2014) Clinical and biochemical characteristic features of metastatic cancer to the sella turcica: an analytical review. Pituitary 17:575\u2013587. https:\/\/doi.org\/10.1007\/s11102-013-0542-9","journal-title":"Pituitary"},{"key":"1758_CR100","doi-asserted-by":"publisher","first-page":"914","DOI":"10.4158\/EP12407.OR","volume":"19","author":"D Ariel","year":"2013","unstructured":"Ariel D, Sung H, Coghlan N et al (2013) Clinical characteristics and pituitary dysfunction in patients with metastatic cancer to the sella. Endocr Pract 19:914\u2013919. https:\/\/doi.org\/10.4158\/EP12407.OR","journal-title":"Endocr Pract"},{"key":"1758_CR101","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1530\/EC-18-0338","volume":"7","author":"A Javanbakht","year":"2018","unstructured":"Javanbakht A, D\u2019Apuzzo M, Badie B, Salehian B (2018) Pituitary metastasis: a rare condition. Endocr Connect 7:1049\u20131057. https:\/\/doi.org\/10.1530\/EC-18-0338","journal-title":"Endocr Connect"},{"key":"1758_CR102","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/neuros\/nyab209","volume":"90","author":"WL Bi","year":"2022","unstructured":"Bi WL, Santagata S (2022) Skull Base Tumors: Neuropathology and Clinical Implications. Neurosurgery 90:243\u2013261. https:\/\/doi.org\/10.1093\/neuros\/nyab209","journal-title":"Neurosurgery"},{"key":"1758_CR103","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1210\/jc.2011-0168","volume":"96","author":"P Famini","year":"2011","unstructured":"Famini P, Maya MM, Melmed S (2011) Pituitary magnetic resonance imaging for sellar and parasellar masses: ten-year experience in 2598 patients. J Clin Endocrinol Metab 96:1633\u20131641. https:\/\/doi.org\/10.1210\/jc.2011-0168","journal-title":"J Clin Endocrinol Metab"},{"key":"1758_CR104","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11102-026-01679-5","volume":"29","author":"RB Dolovac","year":"2026","unstructured":"Dolovac RB, McCormack A, Evans LR et al (2026) Pituitary stalk biopsy - A systematic review of the safety and efficacy of stalk lesion biopsy. Pituitary 29:77. https:\/\/doi.org\/10.1007\/s11102-026-01679-5","journal-title":"Pituitary"},{"key":"1758_CR105","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1210\/jc.2018-01021","volume":"103","author":"S Chiloiro","year":"2018","unstructured":"Chiloiro S, Tartaglione T, Capoluongo ED et al (2018) Hypophysitis Outcome and Factors Predicting Responsiveness to Glucocorticoid Therapy: A Prospective and Double-Arm Study. J Clin Endocrinol Metab 103:3877\u20133889. https:\/\/doi.org\/10.1210\/jc.2018-01021","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01758-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-026-01758-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01758-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:01:50Z","timestamp":1793502110000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-026-01758-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":105,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1758"],"URL":"https:\/\/doi.org\/10.1007\/s11102-026-01758-7","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"assertion":[{"value":"8 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"157"}}